VJHemOnc Podcast
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024
The introduction of Brutons tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the...